Stock data
Climb Bio, Inc. (CLYM)
Climb Bio, Inc. (CLYM) reported net income of -US$59.85M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$67.88M | -US$59.85M | — |
| 2024 | — | — | -US$82.02M | -US$73.90M | — |
| 2023 | — | — | -US$40.27M | -US$35.12M | — |
| 2022 | — | — | -US$45.13M | -US$45.24M | — |
| 2021 | — | — | -US$35.67M | -US$47.48M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$13.50M | — |
| 2026-03-31 | — | -US$13.72M | — |
| 2025-12-31 | — | -US$17.52M | — |
| 2025-09-30 | — | -US$12.89M | — |
| 2025-06-30 | — | -US$8.67M | — |
| 2025-03-31 | — | -US$20.78M | — |
| 2024-12-31 | — | -US$8.42M | — |
| 2024-09-30 | — | -US$8.89M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.